🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for NAFLD - Nonalcoholic Fatty Liver Disease

Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease NCT07051863n/a1 site📍 Lugano Fondazione Epatocentro Ticino The COherence of Scatter Identification and Exclusion Algorithm Study NCT06975579n/a1 site📍 London Institute of Cancer Research, United Kingdom · Tests: Ultrasound image processing Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States NCT05832229Phase 213 sites📍 La Jolla📍 Los Angeles📍 Los Angeles National Institute of Diabetes and Digestive and Kidney Dis… · Tests: Rosuvastatin Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH) NCT06569524Phase 253 sites📍 Lu'an📍 Lu'an📍 Beijing Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Phar… · Tests: TQA2225/AP025 or TQA2225/AP025 Placebo 25mg, TQA2225/AP025 or TQA2225/AP025 Placebo 50mg Androgens and NAFLD Longitudinal Cohort Study NCT06124261n/a2 sites📍 San Francisco📍 Durham University of California, San Francisco A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH NCT06419374Phase 3330 sites📍 Birmingham📍 Homewood📍 Chandler Hoffmann-La Roche · Tests: Pegozafermin, Placebo Digoxin In NASH (CODIN) NCT06588699Phase 22 sites📍 New Haven📍 New Haven Yale University · Tests: Digoxin, Placebo Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) NCT04634643n/a1 site📍 New Haven Yale University · Tests: Usual diet and physical activity A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD NCT07527910Phase 29 sites📍 Tucson📍 Coronado📍 Pasadena Regeneron Pharmaceuticals · Tests: ALN-PNP, Tirzepatide, Placebo The European NAFLD Registry NCT04442334n/a37 sites📍 Antwerp📍 Helsinki📍 Angers Newcastle University Clinical Course and Biomarkers Associated With Nonalcoholic Fatty Liver Disease (NAFLD) in Chinese Patients With Obesity NCT07662356n/a1 site📍 Hong Kong Chinese University of Hong Kong · Tests: Case Group A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients NCT03472157NA1 site📍 Lille University Hospital, Lille · Tests: Lifestyle therapy, Bariatric surgery Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease NCT02863757n/a1 site📍 Hong Kong Humanity and Health Research Centre Nonalcoholic Steatohepatitis in Chinese Children NCT03190538n/a1 site📍 Beijing Humanity and Health Research Centre · Tests: No intervention Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study) NCT07481734Phase 21 site📍 Shenzhen Hudson Biotech · Tests: Tesamorelin, Placebo, Standardized lifestyle counseling A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) NCT06318169Phase 3370 sites📍 Birmingham📍 Chandler📍 Flagstaff Hoffmann-La Roche · Tests: Pegozafermin, Placebo Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis NCT05720663n/a2 sites📍 Rochester📍 Richmond Virginia Commonwealth University · Tests: Standard of care Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance NCT05165706NA1 site📍 Stanford Stanford University · Tests: Dietary Intervention Mediterranean Low Carbohydrate Diet, Dietary Intervention Standard Low Carbohydrate Diet, Dietary … Target of Suv420h1/2 in Hepatocytes NCT06332677NA1 site📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Tests: the main genes and expression by comparing the transcriptomic lipidomic profile Non-Invasive Quantification of Liver Health in NASH (N-QUAN) NCT04054310NA7 sites📍 Chandler📍 Chicago📍 Indianapolis Perspectum · Tests: Liver Multi Scan Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial NCT07193927Phase 21 site📍 Girona AB Biotics, SA · Tests: Lactiplantibacillus plantarum Probiotic Mixture, Placebo comparator containing maltodextrin An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD) NCT06939569n/a1 site📍 Shanghai Shanghai East Hospital Bicalutamide Therapy in Young Women With NAFLD and PCOS NCT05979389Phase 11 site📍 San Francisco University of California, San Francisco · Tests: Bicalutamide 50 mg, Placebo Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH) NCT07631637Phase 216 sites📍 Tucson📍 Tucson📍 Tucson Regeneron Pharmaceuticals · Tests: ALN-CIDEB, Placebo Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal NCT06707129n/a1 site📍 Beijing Beijing Municipal Administration of Hospitals · Tests: life-style PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies NCT04371042n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease NCT05439226NA3 sites📍 Yichang📍 Changsha📍 Changsha State Key Laboratory of Subhealth Intervention Technology · Tests: CMNT diet Digital Early Warning System for Acute Lung Injury in Liver Surgery NCT07070362n/a4 sites📍 Beijing📍 Beijing📍 Chongqing Beijing Tsinghua Chang Gung Hospital Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis NCT07265297Phase 31 site📍 Taipei National Taiwan University Hospital · Tests: Hydrochloroquine, Placebo Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes NCT06035874NA1 site📍 Gurgaon Medanta, The Medicity, India · Tests: Bempedoic acid
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy